TransCode Therapeutics, Inc. (RNAZ): Operatsion rentabellik

TransCode Therapeutics (RNAZ) tovar belgisi

Operatsion foyda marjasi dinamikasi ko'rsatkich qiymati 0.00 ekanligini namoyish etadi. TransCode Therapeutics (RNAZ) dori vositalarini yetkazib berish uchun nanoparticlesdan foydalangan holda saraton metastazlariga qarshi RNA terapiyalarini ishlab chiqmoqda. Biroq, tijorat mahsulotlarining yo'qligi va yuqori tadqiqot xarajatlari joriy foydani yo'qqa chiqaradi. Kompaniya hozirda omon qolish rejimida bo'lib, tashqi aloqalarini vaqti-vaqti bilan beriladigan akademik grantlar bilan cheklamoqda.

RNAZ: TransCode Operatsion marja 04.07.2022 - 19.11.2026

TransCode Therapeutics (RNAZ) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning asosiy tahlili:TransCode Therapeutics
TransCode tayyor mahsulotlari

Notsiklik biotexnologiya kompaniyasi TransCode Therapeutics (RNAZ) uchun ushbu ko'rsatkich operatsion daromadga nisbatan RNA dori vositalarini ishlab chiqishdagi xarajatlarni boshqarish samaradorligining o'lchovi bo'lib xizmat qiladi. Operatsion marja tendentsiyasi orqali aks etgan operatsion foydaning tushumga nisbati biznesning haqiqiy tijorat rentabelligini ochib beradi, bu esa uning makro-barqarorligini va klinik sinovlar davrida YaIM tebranishlaridan mustaqil ravishda faoliyat yuritishning fundamental qobiliyatini tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|Sotuvning operatsion marjasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Operatsion marja|Boundless Bio Inc. (BOLD) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi XCUR (exicuretx.com)|Imunon Inc - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja PHIO (Phio Pharmaceuticals Corp)|Operatsion foyda normasi MBIO|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik